On April 8, 2021, UMDF Science & Alliance Officer, Philip Yeske, Ph.D., presented our latest ‘Clinical Trial Update’. In this webcast, Dr. Yeske talks with Tolga Uz, MD, PhD, Astellas Pharma Global Development Inc. Dr. Uz discusses Astellas ASP0367 . You can see the webcast below.
Clinical Trials Update – Astellas ASP0367
Categories
Recent Posts
- Ask the Mito Doc – March 2024; Q&A
- UMDF Announces Inaugural Venture Philanthropy Investment: The Mito Fund Invests $500k in Pierrepont Therapeutics, Inc. to Help Move a Mitochondrial Disease Therapy Forward
- Powerhouse Podcast #28: Divakar Mithal, MD, PhD
- Research Update from 2023 accelerators Runner-Up Jonathan Dietz, PhD